CHILDREN OF THE UNITED STATES NEED YOUR HELP.  TODAY!

Here's how you can help them.  Right now.

We promise this will only take about one minute of your time.

Welcome ... to "One Minute Activism."

Its incredibly fast, easy, pain-free, costs nothing and best of all it works.

How could it not with thousands of other people just like you who are doing the same thing right now!  Think about it.

Here's all you have to do.

Are you ready?

Let's go to a site called "Contacting The Congress"

The congress site won't link through another website.

So, open a NEW browser, keeping this page open

so that you can follow the directions.  Copy the following

url and paste it into the other browser you opened:

http://www.visi.com/juan/congress/cgi-bin/mailform2.cgi?site=ctc

Type your first and last name, street address, city, state, zip.

Now add your email address and phone number.

When finished, click on the "button" beneath the "phone number" field.

You'll be whisked to another web page.

At the new web page that appears

Click in the "Subject" field.

Delete the "default" message:

An Issue Of Concern To Me

Replace it (by pasting/ typing)  the following text

into the "Subject" box:

SSRI's, Children's Suicides and The FDA

Note: Pasted text will not appear in the "Subject" box

until you click  the "letter box".

Click in the "letter box" area.

Delete the default text that reads:

"I Am Contacting My Members Of Congress"

Replace that with the contents of this DROP DOWN BOX :

                Hold  the left mouse button down  while scrolling to

highlight the entire contents, right click to copy.

Now back to the Letter Box of the email you were in, 

right click in the area and choose "paste".  

You're almost through .....

Now Click on the button that reads

"Preview And Send Your Message"

A new web page appears.

In the lower left hand corner click the button

"Send Your Message Electronically"

YOU'RE DONE!!

One Minute Activism!

Our message is on its way to Congress!

Now that you've helped send our message to Congress

I want to give you something as a way of saying "thanks."

Select one of the following bumper stickers:

Paxil: Unsafe At Any Dose

Zoloft: Unsafe At Any Dose

Prozac: Unsafe At Any Dose

Send an email to chv@comcast.net and let us know which

one you want. Please be sure to include a name and

mailing address so we'll know  where to  send it!

Thank you for helping to make a difference :-)

Please send this webpage to everyone in your address book

whom you think will take one minute to help.

In memory of 'Kara' ... a child who

committed suicide less than 24  hours

after beginning a horrific

'cold turkey' withdrawal from the

SSRI  antidepressant drug, Paxil. "

EMAIL TO USA CONGRESS

AN APPEAL TO ALL VISITORS TO EMAIL USA CONGRESS ON BEHALF OF THE CHILDREN OF THE UNITED STATES WHO, AS YET, ARE STILL BEING PRESCRIBED SSRIs THAT ARE BANNED IN THE UK DUE TO SUICIDAL RISKS INVOLVED.

The email by the  Prisoner of Paxil  website, to which  there is a link on this site's Home Page, can be done here.  It only takes a few moments.  Just follow Rob's simple directions as per his email:

[Original email adapted for website use by permission of  author, 12.3.04]

The Vetting of the FDA's SSRI Pediatric Columbia Group: Dr. Kelly  Posner. Removal of Dr. John Mann. View the entire  FDA Meeting Transcript at: http://www.fda.gov/ohrms/dockets/ac/04/transcript/4006T1.htm "In our efforts to further evaluate the data, we have enlisted the help  of outside experts with particular expertise in the issue of pediatric  depression and suicide, and in particular, we have enlisted a group  from Columbia University, who will objectively reclassify potential  cases of suicidality from all the drug development programs, so that we  may move forward with our more definitive analyses. You will hear  about this from Dr. Kelly Posner in more detail later." — Dr. Russell  Katz addressing the audience in opening remarks at the Monday, February  8th, 2004 FDA hearing regarding the use of SSRI's, suicidality and the  pediatric population. Unless something dramatic occurs Dr. Posner will remain an integral  part of the "Columbia group" referenced above in Dr. Katz's comments.  Dr. Posner is responsible for coordinating the  FDA's so called  "Suicidality Classification Project." By "dramatic" I mean to say: (if)  disclosures of Dr. Posner's personal or family business interests  reveal ties to the pharmaceutical company's whose drugs were the topic  of discussion at this meeting. The public already knows this is the case with at least one member of  the Columbia group whom Dr. Katz references: Dr. John Mann. Just for  starters, Dr. Mann testified on behalf of GlaxoSmithKline (GSK) in what  is known as "the Donald Schnell case." In that case a jury — in a  landmark decision — concluded ingestation of Paxil was the proximate  cause of Mr. Schnell's tragic actions ... whereby Mr. Schnell shot to death  members of his family before turning a gun on himself. Mr. Schnell also  died. GSK subsequently decided to appeal the verdict, but then on second  thought decided not to. A transcript of this stunning trial as well as  (shocking and disturbing) depositions of GSK personnel  (including  David Wheadon) can be found at renowned SSRI expert David Healy's web  site: http://www.healyprozac.com While on the subject of Dr. Healy ... I implore you to read Dr. Healy's  February 19th, 2004 letter to Peter J. Pitts, Associate Commissioner For External Public Relations, FDA.  At minimum, it should raise at  least one of your eyebrows — about a mile high.  A link to that letter  can be found at: http://www.ahrp.org/risks/healy/FDA0204.html I also suggest reading the following letter from Jennifer Tierney: http://www.baumhedlundlaw.com/medissri/paxil/FDAHearing/TierneyLetter.htm But for the moment let's take a closer look at Dr. Posner. Just who is  she? To begin with she actually goes by Dr. Kelly Posner-Gerstenhaber. Dr. Posner-Gerstenhaber graduated from Brown University with honors and  went on to earn a Ph.D. in Clinical Psychology at Yeshiva University,  after completing her doctoral research in pediatric oncology at the  Memorial Sloan-Kettering Cancer Center. She then did an internship and  fellowship at Babies' Hospital, Department of Child Psychiatry,  Columbia-Presbyterian Medical Center. Dr. Posner-Gerstenhaber is a research scientist and the Director of  Clinical Services of the Research Unit for Pediatric  Psychopharmacology, at New York State Psychiatric Institute, Columbia  University. In addition to her research responsibilities — which  include running a number of pediatric clinical trials for industry and  the NIMH — Dr. Gerstenhaber also teaches and directs a training  program. QUESTIONS THAT MUST BE ADDRESSED BY DR. POSNER IMMEDIATELY AND IN DETAIL What pediatric trials? For which drug company(s)? What training program? For which drug company(s)? As part of an international research team (consisting of the neurology  depts. of Harvard, Columbia, and others)  Dr. Posner-Gerstenhaber  traveled to Venezuela on multiple occasions. There she spear-headed the  addition of something called "Evaluation Services," and according to  one source I have "made available greatly-needed psychotropic  medications for (these) suffering children and adolescents." MORE QUESTIONS THAT MUST BE ADDRESSED BY DR. POSNER IMMEDIATELY AND IN  DETAIL: What did your spearheading of "Evaluation Services" entail? What is Evaluation Services? What entity or entities are behind Evaluation Services? Did you participate materially in studies conducted on children and  adolescents in South America? If so, what kind of studies? Were parental consent forms used? Or were these runaway children scooped up off the the streets of a big  city? Which "psychotropic medicines" were employed? Paxil? Prozac? Zoloft? Sponsored by which pharmaceutical company(s)? GSK? Lilly? Pfizer? What was your relationship to pharmaceutical company(s) that provided  the drugs? What quantity of drugs were given, in what doses, and for how long? Did you handle just the "numbers crunching" -- or did you also hand out  drugs? What was the age range of participants? What was the age of the youngest child dosed? 8? 5? 2? Six months? Were any of these drugs given to pregnant teens? How many participants were used? Were there suicides, whether akathasia-induced or withdrawal-induced? What sort of safety monitoring was i n place to safeguard the health of  participants? What sort of documentation occurred? Where is that documentation today? Can you provide any sound reasoning as to why you should not  immediately and publicly answer all of these questions? In closing: Dr. Katz's own remarks are that the "reinterpretation" of  the SSRI pediatric data in question will be done so in an "objective"  manner. Therefore I am calling for the immediate removal of Dr. John  Mann from the "Columbia group," and for the immediate and full vetting  of Dr. Posner-Gerstenhaber. Furthermore, I am calling on FDA to immediately release all names of  persons selected by Dr. Katz and his colleagues who have been selected  as members of "the Columbia group." Dr. Temple (an FDA colleague of  Katz) promised he would do this in a timely manner. More than one month  has passed and Dr. Temple has not made good on his promise. I am also demanding FDA make available — immediately — for public  inspection its Contract For Services with Columbia University relative  to the Suicide Reclassification Project currently headed by Dr. Posner. If you have any questions regarding the (alleged) objective review of  the SSRI-pediatric-suicide data slated to be performed by "the Columbia  group,"   (Dr. Kelly Posner, Dr. John Mann,  et al) and member's ties to  pharmaceutical companies —  they should be directed ASAP to key FDA  personnel as follows: Dr. Temple at: robert.temple@fda.hhs.gov Dr. Katz at: russell.katz@fda.hhs.gov Dr. Laughren at: thomas.laughren@fda.hhs.gov